Outlook for 2025: how Trump and the USPTO will affect life sciences IP

Key developments for the industry this year include a more pro-patent administration and USPTO changes, say Carla Ji-Eun Kim and Deborah Sterling of Sterne Kessler.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

CREATES Act unfairly tips the scales to generics

19 December 2024 The act’s one-sided provisions and its disproportionate remedies cannot pass constitutional muster, argues John Cox of Barnes & Thornburg.

Americas

Trump’s return sparks calls for pro-patent agenda

5 December 2024 As President-elect Donald Trump prepares for his second term, the life sciences industry is calling for predictability, finds Marisa Woutersen.

Americas

President Trump 2.0: Five major areas to watch

7 November 2024 As Donald Trump celebrates a second term, LSIPR looks at how key IP areas could be affected ahead of his return to the Oval Office.

More on this story

Americas

CREATES Act unfairly tips the scales to generics

19 December 2024 The act’s one-sided provisions and its disproportionate remedies cannot pass constitutional muster, argues John Cox of Barnes & Thornburg.

Americas

Trump’s return sparks calls for pro-patent agenda

5 December 2024 As President-elect Donald Trump prepares for his second term, the life sciences industry is calling for predictability, finds Marisa Woutersen.

Americas

President Trump 2.0: Five major areas to watch

7 November 2024 As Donald Trump celebrates a second term, LSIPR looks at how key IP areas could be affected ahead of his return to the Oval Office.

More on this story

Americas

CREATES Act unfairly tips the scales to generics

19 December 2024 The act’s one-sided provisions and its disproportionate remedies cannot pass constitutional muster, argues John Cox of Barnes & Thornburg.

Americas

Trump’s return sparks calls for pro-patent agenda

5 December 2024 As President-elect Donald Trump prepares for his second term, the life sciences industry is calling for predictability, finds Marisa Woutersen.

Americas

President Trump 2.0: Five major areas to watch

7 November 2024 As Donald Trump celebrates a second term, LSIPR looks at how key IP areas could be affected ahead of his return to the Oval Office.